Ausgabe 6/2012
Inhalt (8 Artikel)
Web-Based Patient-Reported Outcomes in Drug Safety and Risk Management
Anjan Kumar Banerjee, Simon Ingate
Eosinophilic Pneumonia in Patients Treated with Daptomycin
Peter W. Kim, Alfred F. Sorbello, Ronald T. Wassel, Tracy M. Pham, Joseph M. Tonning, Sumathi Nambiar
Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs
James E. Tisdale, Heather A. Wroblewski, Brian R. Overholser, Joanna R. Kingery, Tate N. Trujillo, Richard J. Kovacs
Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals
Rikje Ruiter, Loes E. Visser, Myrthe P. P. van Herk-Sukel, Petronella H. Geelhoed-Duijvestijn, Sandra de Bie, Sabine M. J. M. Straus, Peter G. M. Mol, Silvana A. Romio, Ron M. C. Herings, Bruno H. Ch. Stricker
Adverse Drug Reactions in Children — International Surveillance and Evaluation (ADVISE)
Asia N. Rashed, Ian C. K. Wong, Noel Cranswick, Barbara Hefele, Stephen Tomlin, John Jackman, Kenneth Lee, Kam-Lun E. Hon, Jeffrey Ong, Maisoon Ghaleb, Siew Siang Chua, Tea Ming Hui, Wolfgang Rascher, Antje Neubert
Early Detection of Pharmacovigilance Signals with Automated Methods Based on False Discovery Rates
Ismaïl Ahmed, Frantz Thiessard, Ghada Miremont-Salame, Françoise Haramburu, Carmen Kreft-Jais, Bernard Be’gaud, Pascale Tubert-Bitter
Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database
Behrooz K. Shamloo, Pankdeep Chhabra, Andrew N. Freedman, Arnold Potosky, Jennifer Malin, Sheila Weiss Smith